ECHO Researchers Examine the Effect of Perinatal Synthetic Oxytocin Exposure and Maternal BMI on Child Neurodevelopmental Outcomes

Lisa Kurth, PhD

Collaborative ECHO Cohort research led by Lisa Kurth, PhD of the University of Colorado, Anschutz Medical Campus investigates the potential influence of maternal exposure to synthetic oxytocin during childbirth—and the contribution of maternal obesity—on neurodevelopmental outcomes in children. Synthetic oxytocin (e.g., Pitocin, Syntocinon) is a drug commonly used to assist women during childbirth by stimulating uterine contractions.

The researchers examined data from over 12,000 mother-child pairs to look at possible associations between maternal exposure to synthetic oxytocin, maternal pre-pregnancy body mass index (BMI), and childhood ADHD and Autism Spectrum Disorder (ASD). The results of this study found no significant correlation between synthetic oxytocin exposure and the risk of ADHD and ASD in children. However, an unexpected finding in this study was that synthetic oxytocin exposure was associated with a decreased childhood risk of ADHD in children born to mothers with pre-pregnancy obesity. Additionally, mothers with pre-pregnancy obesity demonstrated a modest trend toward labor intervention with synthetic oxytocin. This research, titled “Intrapartum Exposure to Synthetic Oxytocin, Maternal BMI and Neurodevelopmental Outcomes in Children within the ECHO Consortium,” is published in the Journal of Neurodevelopmental Disorders.

Previous studies on the association between synthetic oxytocin and children’s risk of ADHD and ASD have been decidedly mixed, and the potential impact of the mother’s pre-pregnancy BMI on this association has, until now, not yet been examined. This study analyzed data from participating mothers, 48% of whom were exposed to synthetic oxytocin during childbirth, and their children from ECHO Cohort research sites across the U.S.

Although no significant correlation was found between synthetic oxytocin-assisted childbirth and neurodevelopmental outcomes in children, future research may further unravel the effects of childbirth factors such as synthetic oxytocin dosage, maternal labor duration, maternal gestational obesity and Caesarean delivery rationale, indicators of newborn health (e.g., initial Apgar score, meconium stain, newborn birthweight), and maternal BMI at time of delivery on infant well-being in relationship to child neurodevelopmental outcomes. Important next steps include analysis of biospecimens (placental tissue and cord blood) aimed at understanding the specific mechanism(s) of action involved in synthetic oxytocin exposure.

“Casting a wider net and including additional factors will allow future studies to more precisely examine the effects of important perinatal factors, including environmental exposures, and effect modifiers, such as maternal obesity, on child neurodevelopmental outcomes,” said Dr. Kurth.

Read the research summary.

No Significant Correlation Found Between Labor-inducing Drug During Childbirth and Future Risk of ADHD and Autism Spectrum Disorder in Children, Study Finds

<< Back to Research Summaries

No Significant Correlation Found Between Labor-Inducing Drug During Childbirth and Future Risk of ADHD and Autism Spectrum Disorder in Children, Study Finds

Synthetic oxytocin was associated with lower ADHD risk among children born to mothers with pre-pregnancy obesity. Mothers with pre-pregnancy obesity were more inclined to receive labor-inducing medication.

Authors: Lisa Kurth, PhD, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health.

 

Why was this study needed?

More than 50% of U.S. childbirths are assisted with synthetic oxytocin (sOT)—known by trade names such as Pitocin or Syntocinon—a drug that promotes labor by stimulating the muscles in the uterus to contract. As rates of child ADHD and autism spectrum disorder (ASD) diagnoses are steadily rising, researchers have attempted to identify risk factors that might be contributing to these increases. There have been conflicting results from previous studies investigating the link between sOT exposure and childhood risk of ADHD and ASD. Additionally, the potential effect of the mother’s pre-pregnancy body mass index (BMI) on this association has not yet been studied.

 

What were the study results?

Analysis of data from a large and diverse ECHO Cohort sample suggests that maternal exposure to sOT during childbirth was not associated with an increased risk for ADHD or ASD in offspring. Associations did not differ by sex. Unexpectedly, sOT was associated with lower ADHD risk among children born to mothers with pre-pregnancy obesity.

The study also found that 48% of laboring mothers received sOT. Researchers saw slightly higher usage of sOT in mothers with pre-pregnancy obesity.

 

What was this study's impact?

The findings raise questions about how these drugs might affect health outcomes, especially when combined with maternal obesity during pregnancy. Additionally, the findings indicate that maternal obesity may influence the need for interventions during childbirth. These results do not currently support a need to modify the clinical use of sOT during childbirth.

 

What happened during the study?

A team of researchers used statistical analysis to examine the association between sOT exposure during labor and child ADHD or ASD diagnosis. Investigators also evaluated whether maternal pre-pregnancy BMI and child sex affected this correlation.

Note: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

 

Who was involved?

This study included over 12,000 mother-child pairs from 44 ECHO Cohort research sites across the U.S. Of the mothers participating in this study, 48% were exposed to sOT during childbirth.

 

What happens next?

More research is needed to evaluate if the dosage and duration of sOT has any influence on children's neurodevelopment. Future studies may clarify how environmental exposures and other contributing factors, such as delivery method and maternal obesity at delivery, influence a child’s neurodevelopment. Examining maternal/fetal biospecimens could also reveal how this exposure affects mothers and babies.

 

Where can I learn more?

Access the full journal article, titled “Intrapartum Exposure to Synthetic Oxytocin, Maternal BMI, and Neurodevelopmental Outcomes in Children within the ECHO Consortium” in the Journal of Neurodevelopmental Disorders.

 

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published May 26, 2024

Read the associated article.

Obesity and Diabetes During Pregnancy Linked to Higher Risk of Autism-Related Traits in Children

<< Back to Research Summaries

Obesity and Diabetes During Pregnancy Linked to Higher Risk of Autism-Related Traits in Children

Authors: Kristen Lyall, Christine Ladd-Acosta, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) program, Office of The Director, National Institutes of Health.

 

What were the study results?

Maternal obesity and gestational diabetes were associated with indicators of autism-related social behaviors. Investigators did not see increases in these behaviors for children of mothers with preeclampsia or gestational hypertension. Neither preterm birth or low birth weight, which are common complications of obesity and gestational diabetes, did not seem to drive the associations with these pregnancy conditions.

 

What was the study's impact?

Obesity and gestational diabetes are common pregnancy conditions, so understanding their impact on the developing child is an important public health issue. This study suggests that these conditions may increase the likelihood of ASD-related traits, highlighting the need for better prenatal care and more monitoring of pregnant women experiencing conditions like obesity.

 

Why was this study needed?

Many studies have linked childhood autism diagnosis back to maternal health conditions during pregnancy—like obesity, gestational diabetes (high blood sugar during pregnancy), gestational hypertension (high blood pressure during pregnancy), and preeclampsia (high blood pressure during pregnancy and signs of kidney/liver damage). But less is known about how these conditions may relate to subtler changes in child social development. This research looks at how risk factors of obesity, gestational diabetes, gestational hypertension, and preeclampsia relate to autism-related traits like social communication more broadly.

 

Who was involved?

This study included nearly 7,000 participants from 40 ECHO cohorts across the United States. Eight of these cohorts included participants considered to be at higher risk for autism spectrum disorder (ASD) based on known risk factors. The study only included cohorts that collected information on at least one of the four pregnancy conditions listed above and child social development/autism-related behaviors. Children were between the ages of 2.5-18 years, with an average age of approximately 8 years old.

 

What happened during the study?

The research team pulled together information on maternal health conditions during pregnancy, maternal age, child social development/autism-related behaviors, and participant demographics. They then examined the relationship between each pregnancy condition, separately and in combination, and child social development outcomes.

 

What happens next?

More work is needed to determine the underlying biologic and social mechanisms linking maternal obesity to child social behaviors and autism.

 

Where can I learn more?

Access the full journal article, titled “Cardiometabolic pregnancy complications in association with autism-related traits as measured by the Social Responsiveness Scale in ECHO” in the American Journal of Epidemiology.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published March 31, 2022

 

Access the associated article.

Read More Research Summaries about Pregnancy and Autism

Does Smoking During Pregnancy Increase the Childs Risk for Autism?

Author(s): Rashelle J. Musci, Irva Hertz-Picciotto, et al.

ECHO Study Suggests Link Between Smoking During Pregnancy and Autism-Related Traits in Children

<< Back to Research Summaries

ECHO Study Suggests Link Between Smoking During Pregnancy and Autism-Related Traits in Children

Authors: Rashelle J. Musci, Irva Hertz-Picciotto, et al.

 

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) program, Office of The Director, National Institutes of Health.

 

What were the study results?

Smoking before or during pregnancy was consistently associated with ASD traits, such as symptoms of social impairments. Additionally, babies born at full term had a somewhat higher risk of receiving an ASD diagnosis as a child if their mothers smoked before or during the pregnancy.

More counseling is needed for pregnant women or those planning a pregnancy to help them understand how these potential risks for the child’s behavioral development add to other poor outcomes associated with smoking during pregnancy, such as low birthweight, increased likelihood of fetal or infant death, asthma in early childhood, or attention deficit hyperactivity disorder (ADHD).

Footnote: Results reported here represent results from 11 or seven studies, depending on the outcome. Other or future studies may provide new information or different results. Consult your healthcare professional for guidance on how to limit your unborn child’s exposure to tobacco smoke. However, please also note that you have a greater chance of improving your child’s health and their social and behavioral development the sooner you quit or reduce smoking.

 

What was the study's impact?

There are many reasons for women to limit their exposure to tobacco smoke during pregnancy—tobacco smoke increases risk for low birthweight, ectopic pregnancy, a premature delivery, or fetal/infant death. Less research has been done to learn how tobacco smoke can influence children’s health, although studies have linked prenatal smoking to higher childhood asthma and ADHD risk. This study shows how prenatal exposure to cigarette smoke may also harm a child’s social development. Social skills can be important for success in school and getting along with others. Doctors, child educators, and other health and daycare providers should also know that children exposed to prenatal cigarette smoke may also be at higher risk for developing ASD.

 

Why was this study needed?

Previous studies provide varying results on how tobacco smoke exposure during pregnancy may affect risk for autism spectrum disorder (ASD) in children. Exposures to air pollution, which has many of the same chemicals as tobacco smoke but at lower levels, have also been linked with ASD. ASD is a complex condition that involves not only trouble in social interactions but also communication problems and patterns of repetitive behaviors or narrow interests.

The research team set out to conduct a study with participants from across the U.S. that could clear up inconsistencies found in previous research. Additionally, no other research has looked at the relationship between maternal tobacco smoking and milder autism-like symptoms of social impairment.

 

Who was involved?

Researchers studied approximately 11,000 children in 13 cohorts around the U.S. who either had a diagnosis of ASD, social impairment measurable on the Social Responsive Scale, or both. There also had to be information on exposure to prenatal smoking and other factors that could influence the study results.

 

What happened during the study?

Researchers pulled together and analyzed results from each cohort related to maternal smoking behaviors before or during pregnancy and childhood ASD diagnosis or ASD-related social impairment. The team took specific actions to prevent other factors related to the children and mothers from affecting the quality and consistency of the data.

 

What happens next?

Future studies can help researchers identify when babies are most at-risk to cigarette smoke exposure and how other factors associated with prenatal smoking may contribute to negative health outcomes.

 

Where can I learn more?

Access the full journal article, titled “Maternal Tobacco Smoking and Offspring Autism Spectrum Disorder or Traits in ECHO Cohorts” in Autism Research.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published February 24, 2022

 

Access the associated article.

 

 

Read More Research Summaries about Chemical Exposures and Pregnancy

The Effect of Maternal PFAS Exposure on Prenatal Growth in Black Women

Author(s): Che-Jung Chang, et al.

How Chemical Exposures in Pregnancy Affect Gene Changes in the Placenta

Author(s): Alison Paquette, Sheela Sathyanarayana, et al.

Do chemicals that break down slowly in the environment affect how long it takes to become pregnant?  

Author(s): Linda Kahn, Alison Hipwell, Kim Harley, Pam Factor-Litvak, Michele Klein-Fedyshin, Christine Porucznik, Eva Siegel, Yeyi Zhu

A review of studies that look at whether exposure to common non-persistent chemicals in consumer products delays the time it takes to become pregnant

Author(s): Alison E. Hipwell, Linda G. Kahn, Pam Factor-Litvak, et al